Investors

SEC Filings

SEC Filings

Filing date	Form	Description	View
July 2, 2020	3	Initial filing by director officer or owner of more than ten percent.	0000899243-20-018265.pdf 0000899243-20-018265.rtf 0000899243-20-018265.xls View HTML
January 28, 2021	3	Initial filing by director officer or owner of more than ten percent.	0001562180-21-000573.pdf 0001562180-21-000573.rtf 0001562180-21-000573.xls View HTML
February 18, 2021	3	Initial filing by director officer or owner of more than ten percent.	0001562180-21-001242.pdf 0001562180-21-001242.rtf 0001562180-21-001242.xls View HTML
November 3, 2021	3	Initial filing by director officer or owner of more than ten percent.	0001562180-21-006800.pdf 0001562180-21-006800.rtf 0001562180-21-006800.xls View HTML
July 18, 2023	3	Initial filing by director officer or owner of more than ten percent.	0001562180-23-005953.pdf 0001562180-23-005953.rtf 0001562180-23-005953.xls View HTML
January 27, 2014	DRS/A	mendment to a previously filed DRS	0000950123-14-000635.pdf 0000950123-14-000635.rtf 0000950123-14-000635.xls View HTML
March 19, 2019	NT 10-K	Notification that form 10-K will be submitted late	0001193125-19-078796.pdf 0001193125-19-078796.rtf 0001193125-19-078796.xls View HTML
August 10, 2023	NT 10-Q	Notification that form type 10-Q will be submitted late	0001517022-23-000025.pdf 0001517022-23-000025.rtf 0001517022-23-000025.xls View HTML
April 30, 2015	DEF 14A	Official notification to shareholders of matters to be brought to a vote ("Proxy")	0001193125-15-159076.pdf 0001193125-15-159076.rtf 0001193125-15-159076.xls View HTML
April 29, 2016	DEF 14A	Official notification to shareholders of matters to be brought to a vote ("Proxy")	0001193125-16-569284.pdf 0001193125-16-569284.rtf 0001193125-16-569284.xls View HTML

Data provided by Kaleidoscope.

Print Page

Email Page

Contact IR

Email Alerts

Tear Sheet

Akebia Therapeutics, Inc.
245 First Street, Suite 1400
Cambridge, MA 02142

Driving Directions

+1 617.871.2098 phone
+1 617.871.2099 fax